Research map: Cardiac AAV gene therapy: Translational lessons from intracoronary cardiomyocyte-targeted delivery

Back to the article

Papers in this map

  1. Adeno-associated virus vector as a platform for gene therapy delivery · Dan Wang · 2019 · 2488 citations · Cited by this paper
  2. Decoding preeclampsia: A fusion of multi-view machine learning and multi-omics to identify putative inflammation-related mechanisms · 2026 · Related
  3. Immune responses to AAV vectors: overcoming barriers to successful gene therapy · Federico Mingozzi · 2013 · 960 citations · Cited by this paper
  4. Y-RNAs and their fragments reflect kidney injury in diabetic kidney disease · 2026 · Related
  5. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) · Mariell L Jessup · 2011 · 763 citations · Cited by this paper
  6. Quieting the carrier: Matching delivery to immunology in anti-inflammatory mRNA therapy · 2026 · Related
  7. Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome · Evangelia Galani Kranias · 2012 · 545 citations · Cited by this paper
  8. Polyamines are i-Motif disruptors · 2026 · Related
  9. Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease · Barry Greenberg · 2024 · 91 citations · Cited by this paper
  10. Codon-Optimized Npc1 mRNA corrects Niemann-Pick type C1 disease phenotypes in vitro and in vivo · 2026 · Related
  11. The Phospholamban Journey 4 Decades After Setting Out for Ithaka · Evangelia Galani Kranias · 2017 · 28 citations · Cited by this paper
  12. Neonatal expression of human FMRP isoform corrects cortical deficits and improves behavior in a mouse model of fragile X syndrome · 2026 · Related
  13. Cardiotropic AAV gene therapy for heart failure: a phase 1 trial · Timothy D. Henry · 2025 · 28 citations · Cited by this paper
  14. Intranasal Tat-modified PEG-PCL nanomicelles delivering anti-RelA siRNA attenuate ischemia-reperfusion injury in transient MCAO mice · 2026 · Related
  15. First-in-human study of TN-201, an AAV9 gene replacement therapy in MYBPC3 -associated hypertrophic cardiomyopathy: initial safety, pharmacodynamic, and imaging results from MyPEAK-1 · Milind Y. Desai · 2025 · 20 citations · Cited by this paper
  16. Antisense Peptide Nucleic Acids Targeting Ribosomal Protein Genes: A Novel Strategy Against Carbapenem-resistant Acinetobacter baumannii · 2026 · Related
  17. AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: rationale and study design of the GenePHIT trial · Timothy D. Henry · 2026 · 2 citations · Cited by this paper
  18. To scramble or not: steric blocking 2′-MOE/PS control antisense oligonucleotides across cellular models · 2026 · Related
  19. ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity · 2026 · Related

Source: OpenAlex (CC0)